Combating Antimicrobial Resistance in the Post-Genomic Era: Rapid Antibiotic Discovery

Molecules. 2023 May 19;28(10):4183. doi: 10.3390/molecules28104183.

Abstract

Constantly evolving drug-resistant "superbugs" have caused an urgent demand for novel antimicrobial agents. Natural products and their analogs have been a prolific source of antimicrobial agents, even though a high rediscovery rate and less targeted research has made the field challenging in the pre-genomic era. With recent advancements in technology, natural product research is gaining new life. Genome mining has allowed for more targeted excavation of biosynthetic potential from natural sources that was previously overlooked. Researchers use bioinformatic algorithms to rapidly identify and predict antimicrobial candidates by studying the genome before even entering the lab. In addition, synthetic biology and advanced analytical instruments enable the accelerated identification of novel antibiotics with distinct structures. Here, we reviewed the literature for noteworthy examples of novel antimicrobial agents discovered through various methodologies, highlighting the candidates with potent effectiveness against antimicrobial-resistant pathogens.

Keywords: antibiotics; antimicrobial resistance; biosynthesis gene clusters; genome mining; natural products.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Biological Products* / chemistry
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Computational Biology
  • Drug Resistance, Bacterial
  • Genome, Bacterial
  • Genomics

Substances

  • Anti-Bacterial Agents
  • Biological Products

Grants and funding

This work is supported by the Konneker Research Fund, Edison Biotechnology Institute, the Translational Biomedical Sciences program at Ohio University, and John J. Kopchick Research Fellowship Award to Yuehan Yang.